This change only applies to weight loss drugs (e.g., GLP-1 and non-GLP-1 drugs) when they are prescribed solely for weight loss and not for any other medical conditions that the FDA has approved them for, the company said in a statement
Doctors and consumers have a role to play, too
Tracking SHBG is useful because changes alter free hormone availability
ROS can promote cell proliferation, DNA damage, and inflammation, driving malignant transformation
The committee is scheduled to meet once more in February 2027, again to discuss lifting restrictions on peptides: LL-37, GHK-Cu, Dihexa, Melanotan II, and PEG-MGF
Truveta Data provides the most representative, complete, and timely patient journey data, including full patient medical records, notes, and images, for more than 120 million patients across the US